Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Zhen J. Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2065-5296; OpenAlex author ID A5007418183; NIH RePORTER profile ID 9115010. Sources: ClinicalTrials.gov.

Their work

Papers
15 (first author 1, last author 2)
Trials
2 (principal investigator on 2)
Grants
2
Labs led
1
Collaborators
55
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 1 paper · 2020: 5 papers, 1 trial · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper, 1 trial · 2025: 2 papers · 2026: 1 paper, 2 grants

Papers 15

  1. Pancreatic Cancer Screening and Early Detection: Where Are We Now? Co-author DOI 10.1148/rg.250146↗
  2. Advancements in early detection of pancreatic cancer: the role of artificial intelligence and novel imaging techniques. Co-author DOI 10.1007/s00261-024-04644-7↗
  3. Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Di… Co-author DOI 10.2214/ajr.24.32160↗
  4. Hyperpolarized 13C Metabolic MRI of Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1002/jmri.29162↗
  5. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… First author DOI 10.1007/s00261-022-03693-0↗
  6. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC … Co-author DOI 10.1007/s00261-019-02289-5↗
  7. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, upda… Co-author DOI 10.1007/s00261-019-02290-y↗
  8. Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional im… Co-author DOI 10.1007/s00261-020-02723-z↗
  9. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Co-author DOI 10.1172/jci136760↗
  10. Estimation of Fractional Extracellular Space at CT for Predicting Chemotherapy Response and Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2214/ajr.19.22462↗
  11. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stra… Co-author DOI 10.1097/pas.0000000000001152↗
  12. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s00261-017-1374-2↗
  13. The Role of MR Imaging in Pancreatic Cancer. Last author DOI 10.1016/j.mric.2018.03.004↗
  14. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI. Co-author DOI 10.2214/ajr.18.19602↗
  15. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? Co-author DOI 10.1002/jso.24375↗

Trials 2

  1. Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer Principal investigator NCT06600906↗
  2. Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma Principal investigator NCT04565327↗

Grants 2

  1. Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy R01CA256969↗
  2. Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer R01CA280071↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ajit Harishkumar Goenka · 5 shared papers, 1 shared grant, 2018–2026 · strength 1.88
  2. Jeremy William Gordon · 1 shared paper, 1 shared grant, 2024–2026 · strength 1.47
  3. Eric Andrew Collisson · 4 shared papers, 1 shared grant, 2018–2026 · strength 1.39
  4. Avinash R. Kambadakone · 7 shared papers, 2020–2026 · strength 1.14
  5. Elizabeth M. Hecht · 6 shared papers, 2020–2026 · strength 1.04
  6. Chenchan Huang · 3 shared papers, 2025–2026 · strength 0.73
  7. Marc Zins · 5 shared papers, 2020–2025 · strength 0.58
  8. Erik V. Soloff · 5 shared papers, 2020–2025 · strength 0.58
  9. Andrew H. Ko · 5 shared papers, 2016–2024 · strength 0.56
  10. Samuel Joseph Galgano · 3 shared papers, 2023–2025 · strength 0.56
  11. Linda Chi Hang Chu · 3 shared papers, 2023–2025 · strength 0.56
  12. Margaret A. Tempero · 5 shared papers, 2016–2020 · strength 0.44
  13. Eric Peter Tamm · 4 shared papers, 2020–2023 · strength 0.41
  14. Priya Bhosale · 4 shared papers, 2020–2023 · strength 0.41
  15. Atif Zaheer · 3 shared papers, 2020–2025 · strength 0.39
  16. Richard Kinh Gian · 3 shared papers, 2020–2025 · strength 0.39
  17. Naveen M. Kulkarni · 3 shared papers, 2020–2023 · strength 0.31
  18. Olga Rachel Brook · 3 shared papers, 2020–2023 · strength 0.31
  19. Lorenzo Mannelli · 3 shared papers, 2020–2023 · strength 0.31
  20. Parag P. Tolat · 3 shared papers, 2020–2023 · strength 0.31
  21. Benjamin M. Yeh · 3 shared papers, 2018–2020 · strength 0.31
  22. Jin Peng He · 2 shared papers, 2023–2025 · strength 0.29
  23. Lyndon Luk · 2 shared papers, 2023–2025 · strength 0.29
  24. Candice W. Bolan · 2 shared papers, 2023–2025 · strength 0.29
  25. Carlos F. Fernandez-del Castillo · 1 shared paper, 2026 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.